Category: Drugs and Pharmaceuticals
-
iCell Gene Therapeutics Announces CAR-T Oral and Poster Presentations at 61st American Society of Hematology Annual Meeting
STONY BROOK, N.Y. — iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, announced today that it will give oral and poster presentations related to its BCMA-CD19 cCAR and CD4-specific CAR programs at the 61st American Society of Hematology (ASH) Annual Meeting to…
-
C Diff Foundation Raises Clostridioides difficile Awareness in St. Louis on Nov. 6-7 at 7th Annual International Conference and Health EXPO
ST. LOUIS, Mo. — C Diff Foundation announced today that the 7th Annual International C. diff. Conference and Health EXPO is honored to welcome over 30 international topic-experts dedicated in disciplines of healthcare, pharma, biotech, academia, and Government agencies. November 6 – 7, 2019 at the DoubleTree by Hilton Westport Hotel.
-
BioAdaptives, Inc. Announces Return to Fully Reporting and Appointment of President
LAS VEGAS, Nev. — BioAdaptives, Inc. (OTC BB: BDPT) announced the Company’s return to a fully-reporting entity, and the appointment of Mr. Robert W. Ellis as its new President, reporting to Dr. Edward E. Jacobs, Jr.
-
2019 Lupus Insight Prize Awarded to Dr. Ignacio Sanz: Recognizes Studies of Harmful Immune Cells in Lupus
BOSTON, Mass. — The Lupus Research Alliance has awarded its 2019 Lupus Insight Prize to Ignacio Sanz, MD, for discovering that certain little-understood immune system cells are a major source of the harmful proteins that promote lupus symptoms. His work could spark new treatments for the disease and help doctors determine which patients could benefit…
-
C Diff Foundation Recognizes Rebiotix CEO with 2019 ‘Above and Beyond’ Award
NEW PORT RICHEY, Fla. — The C. Diff Foundation Board of Directors announced today that the 2019 “Above and Beyond” Award will be presented to Rebiotix CEO Lee Jones in Roseville, Minnesota. The award, given to one recipient annually, is given to a person or organization that show extraordinary dedication to C. diff patient safety,…
-
Pet King Brands Celebrates 20 Years as a Leader in the Pet Health Products Industry
WESTMONT, Ill. — Pet health products company, Pet King Brands, Inc. – the maker of veterinarian-recommended brands ZYMOX(R) Dermatology and Oratene(R) Brushless Oral Care – celebrates 20 years of helping pets find relief from problematic ear, skin and mouth conditions.
-
Leading Companies to Support C Diff Foundation 6th Annual International C.diff. Conference and Health EXPO, Nov. 8-9, Philadelphia
PHILADELPHIA, Pa. — The C Diff Foundation is honored to welcome leading companies to the 6th Annual International “C.diff. Awareness Conference and Health EXPO,” as they come together to make a global difference. These companies are dedicated to the prevention, diagnostics, treatments, environmental safety products and services focused on C.difficile infections and Healthcare-associated infections and…
-
Healthcare Tech Outlook Names Delta Care Rx a Top 10 Pharmacy Management Solution Provider
FREMONT, Calif. — Delta Care Rx, a leading pharmaceutical innovator in end of life care, has been named one of the “Top 10 Pharmacy Management Solution Providers of 2018,” according to Healthcare Tech Outlook, a digital and print magazine publication of Valley Media, Inc.
-
Alejandro Arboleda Named 2018 Koch Kellan Scholar
PORTLAND, Ore. — Paragon BioTeck, Inc., an ophthalmic pharmaceutical and medical device company, announced today that Alejandro Arboleda has been named its 2018 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and…